Zobrazeno 1 - 10
of 640
pro vyhledávání: '"A, Magheli"'
Autor:
Jacewicz, Maciej *, Günzel, Karsten, Rud, Erik, Sandbæk, Gunnar, Magheli, Ahmed, Busch, Jonas, Hinz, Stefan, Baco, Eduard
Publikováno v:
In The Lancet Infectious Diseases October 2022 22(10):1465-1471
Autor:
Caren Hilger, Martin Schostak, Stephan Neubauer, Ahmed Magheli, Thomas Fydrich, Silke Burkert, Friederike Kendel
Publikováno v:
BMC Urology, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Treatment for localized prostate cancer (PCa) can cause long-term changes in erectile functioning. However, data on the importance of sexuality and possible consequences of altered erectile functioning on self-esteem in men with l
Externí odkaz:
https://doaj.org/article/f5dcd912ddb04accaacf66f1b3fe38fe
Autor:
Maciej Jacewicz, Karsten Günzel, Erik Rud, Gunnar Sandbæk, Ahmed Magheli, Jonas Busch, Stefan Hinz, Eduard Baco
Publikováno v:
The Lancet Infectious Diseases. 22:1465-1471
The benefit of antibiotic prophylaxis is uncertain when performing transperineal prostate biopsies. Judicious use of antibiotics is required as antimicrobial resistance increases worldwide. We aimed to assess whether antibiotic prophylaxis can be omi
Autor:
Alain Ravaud, Maria Lechuga, Anup Patel, Hardev S. Pandha, Allan J. Pantuck, Brigitte Laguerre, Olga Valota, Michelle Casey, Sherry Li, Bernard Escudier, Frede Donskov, Ahmed Magheli, Robert J. Motzer, Michael Staehler, Jean-Francois Martini, Daniel J. George
Association between DFS and genotype subgroups within each treatment group or the combined sunitinib and placebo groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20f4893c777a90e7110f194d0e8bb902
https://doi.org/10.1158/1078-0432.22468418.v1
https://doi.org/10.1158/1078-0432.22468418.v1
Autor:
Alain Ravaud, Robert J. Motzer, Michael Staehler, Olga Valota, Xun Lin, Rachel Li, Phillip G. Febbo, Audrey D. Goddard, Dejan Knezevic, Margarita Lopatin, Christer Svedman, Ahmed Magheli, Jean-Francois Martini, Bernard Escudier, Brian I. Rini
Distribution of RS results in T3 patients in the gene signature cohort. Abbreviations: RS, recurrence score; T3, stage III tumor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3047e3d76bf561fc26cdca2d4f965e14
https://doi.org/10.1158/1078-0432.22470153.v1
https://doi.org/10.1158/1078-0432.22470153.v1
Autor:
Alain Ravaud, Robert J. Motzer, Michael Staehler, Olga Valota, Xun Lin, Rachel Li, Phillip G. Febbo, Audrey D. Goddard, Dejan Knezevic, Margarita Lopatin, Christer Svedman, Ahmed Magheli, Jean-Francois Martini, Bernard Escudier, Brian I. Rini
Purpose: Adjuvant sunitinib prolonged disease-free survival (DFS; HR, 0.76) in patients with locoregional high-risk renal cell carcinoma (RCC) in the S-TRAC trial (ClinicalTrials.gov NCT00375674). The 16-gene Recurrence Score (RS) assay was previousl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5decd5cf3fd0ebc7b81f4433c5843aec
https://doi.org/10.1158/1078-0432.c.6527442.v1
https://doi.org/10.1158/1078-0432.c.6527442.v1
Autor:
Robert H. Getzenberg, Daniel W. Chan, Lori J. Sokoll, Ahmed Magheli, Robert E. Schoen, Eddy S. Leman
Supplementary Figures S1-S2 from Evaluation of Colon Cancer–Specific Antigen 2 as a Potential Serum Marker for Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6d692b02df399a7f11862763fa950f
https://doi.org/10.1158/1078-0432.22440820
https://doi.org/10.1158/1078-0432.22440820
Autor:
Alain Ravaud, Maria Lechuga, Anup Patel, Hardev S. Pandha, Allan J. Pantuck, Brigitte Laguerre, Olga Valota, Michelle Casey, Sherry Li, Bernard Escudier, Frede Donskov, Ahmed Magheli, Robert J. Motzer, Michael Staehler, Jean-Francois Martini, Daniel J. George
Purpose:In the S-TRAC trial, adjuvant sunitinib prolonged disease-free survival (DFS) versus placebo in patients with loco-regional renal cell carcinoma at high risk of recurrence after nephrectomy. An exploratory analysis evaluated associations betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57c0e3a8f3ac4c3dbcb827dde461ff88
https://doi.org/10.1158/1078-0432.c.6526928
https://doi.org/10.1158/1078-0432.c.6526928
Autor:
Alain Ravaud, Robert J. Motzer, Michael Staehler, Olga Valota, Xun Lin, Rachel Li, Phillip G. Febbo, Audrey D. Goddard, Dejan Knezevic, Margarita Lopatin, Christer Svedman, Ahmed Magheli, Jean-Francois Martini, Bernard Escudier, Brian I. Rini
Patient baseline characteristics in the placebo versus sunitinib arm: all T3 patients in the gene signature cohort. aN0 or NX, any Fuhrman grade, ECOG PS 0 or Fuhrman grade 1 and ECOG PS ï,³1. bN0 or NX, Fuhrman grade {greater than or equal to}2, E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::146ccd52111206a47b08f5d7da08bb6b
https://doi.org/10.1158/1078-0432.22470147.v1
https://doi.org/10.1158/1078-0432.22470147.v1
Autor:
Robert H. Getzenberg, Daniel W. Chan, Lori J. Sokoll, Ahmed Magheli, Robert E. Schoen, Eddy S. Leman
Purpose: A blood test to detect colon cancer at a preventable stage would represent a major advancement. We have previously identified colon cancer–specific markers using focused proteomics analysis of nuclear structural proteins. Two of these mark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a4db0160a1197cd561ab63b5b6a05c
https://doi.org/10.1158/1078-0432.c.6518089
https://doi.org/10.1158/1078-0432.c.6518089